MedPath

VIVATECH INTERNATIONAL, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee

Phase 2
Recruiting
Conditions
Osteoarthritis
Interventions
Biological: [StroMed + platelet rich plasma (PRP)]
Biological: [PRP] platelet rich plasma
First Posted Date
2016-07-26
Last Posted Date
2023-08-07
Lead Sponsor
VivaTech International, Inc.
Target Recruit Count
4000
Registration Number
NCT02844751
Locations
🇺🇸

VivaTech International, Inc., Grove City, Pennsylvania, United States

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip

Phase 2
Recruiting
Conditions
Osteoarthritis
Interventions
Biological: [StroMed + platelet rich plasma (PRP)]
First Posted Date
2016-07-26
Last Posted Date
2023-08-07
Lead Sponsor
VivaTech International, Inc.
Target Recruit Count
4000
Registration Number
NCT02844764
Locations
🇺🇸

VivaTech International, Inc., Grove City, Pennsylvania, United States

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder

Phase 2
Recruiting
Conditions
Osteoarthritis
Interventions
Biological: [StroMed + platelet rich plasma (PRP)]
First Posted Date
2016-07-26
Last Posted Date
2023-08-07
Lead Sponsor
VivaTech International, Inc.
Target Recruit Count
4000
Registration Number
NCT02844738
Locations
🇺🇸

VivaTech International, Inc., Grove City, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath